This document is a review of the 2011 guidance and provides recommendations and guidance relating to the prescribing in Wales of denosumab (Prolia) for the prevention of osteoporotic fractures in postmenopausal women, and is intended to complement NICE TA204.
⇩ Prescribing of Denosumab (Prolia) in Wales: Review 255KB (PDF) |
⇩ Shared Care Protocol 201KB (PDF) |
(October 2013)